News Headlines

  1. WCG Acquires Statistics Collaborative, A Biostatistical Consultancy Specializing In Pharmaceutical And Biologics Clinical Trials 1/23/2020

    WCG (WIRB-Copernicus Group), the world's leading provider of solutions that measurably improve the quality and efficiency of clinical trials, today announced its acquisition of Statistics Collaborative, Inc. Based in Washington, DC, Statistics Collaborative has almost 30 years’ experience providing highly specialized biostatistical consulting services to developers of new drugs and biologics.

  2. Akcea And Ionis Report Positive Topline Phase 2 Results Of AKCEA-APOCIII-LRx 1/22/2020

    Akcea Therapeutics, Inc. a majority-owned affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc. today announced positive topline results from the Phase 2 study of AKCEA-APOCIII-LRx in the treatment of patients with hypertriglyceridemia who are at risk for or have established cardiovascular disease (CVD).

  3. Signant Health Finds Growing Econsent Adoption Forecasts And The Importance Of Eclinical Integration In Latest ‘State Of eConsent’ Survey 1/16/2020

    Signant Health, released the findings from its latest “State of eConsent” report today, highlighting the sentiments, successes, and challenges of eConsent practitioners around the world.

  4. TrialScope Engage™ Embedded A Top Innovation For 2019 1/14/2020

    TrialScope Engage™ Embedded technology was named one of the most innovative life sciences products of the year. The solution is designed to help sponsors improve patient engagement and increase trial transparency. 

  5. Patient-Data Platform Raremark Enhances Executive Team To Accelerate Progress In Rare Disease Research 1/14/2020

    Raremark, the leading patient-data platform in rare disease, is pleased to announce additions to its executive team to speed the company’s pursuit of more treatments for rare medical conditions.

  6. Advarra Announces Turnkey Service For Local IRB Offices At Health Systems And Hospitals 1/13/2020

    Advarra, the premier provider of institutional review board (IRB), institutional biosafety committee (IBC), research quality and compliance consulting services, and standards-based research technology solutions announces Advarra GPS—a completely managed service to guide, protect, and streamline research programs for health systems, hospitals, and academic medical centers.

  7. Veeva Introduces New Application To Speed Payments To Clinical Research Sites 1/13/2020

    Vault Payments enables sponsors and CROs to automatically create, track, and report payments in Vault CTMS for greater accuracy and visibility.

  8. AMO Pharma Announces Initiation Of Planned Pivotal Clinical Trial For Myotonic Dystrophy Following $35M Fund Raise 1/9/2020

    AMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceutical company focusing on rare, childhood-onset neurogenetic disorders with limited or no treatment options, today announced the initiation of patient enrollment in the company's planned pivotal clinical trial for AMO-02 in the treatment of congenital myotonic dystrophy.

  9. Parexel Unveils Combined Regulatory & Access Consulting Organization To Help Customers Optimize Delivery Of New Therapies To Patients 1/9/2020

    Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to improve world health, from Clinical through Commercialization, today unveiled its fully-integrated Regulatory & Access consulting organization designed to optimize clinical development from the earliest stages.

  10. Veeva SiteVault Free Now Available To Simplify Study Execution At Clinical Research Sites 1/8/2020

    Sites now have access to a free eRegulatory application to simplify regulatory compliance and speed study execution.